APA citáció

Puskás László, Mán Imola, Szebeni Gábor, Tiszlavicz László, Tsai Susan, & James Michael A. (2016). Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.

Chicago Style (17th ed.) Citation

Puskás László, Mán Imola, Szebeni Gábor, Tiszlavicz László, Tsai Susan, and James Michael A. Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling. 2016.

MLA idézés

Puskás László, et al. Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling. 2016.